You are here

IN-PROCESS CONTROLS IN THE MANUFACTURING PROCESS DESIGN AND DEVELOPMENT OF OPHTHALMIC APPLICATIONS

Journal Name:

Publication Year:

Author Name
Abstract (2. Language): 
Facilities and processes involved in pharmaceutical production affects the quality of the product. manufacturing processes should meet the requirements of Good Manufacturing Practices, especially with regard to cross-contamination. Raw material and equ inspections as well as in-process controls are an integral part of process control. The development of a drug product is a lengthy process involving drug discovery, laboratory testing, animal studies, clinical trials and regulatory registration. Many regulatory agencies across the world require that the drug product should be tested for its identity, strength, quality, purity and stability before it can be released for distribution and use. For this reason, pharmaceutical validation and process controls are important in spite of the problems that may be encountered while performing the same. The following information is intended to provide very broad guidelines concerning the main steps to be followed during production of ophthalmic preparations, indi those that are the most important. Throughout manufacturing, certain procedures should be validated and monitored by carrying out appropriate in process controls
FULL TEXT (PDF): 
126-148

REFERENCES

References: 

1. Jatto E and Okhamafe AO: An Overview
of Pharmaceutical Validation and
Process Controls in Drug Development,
Tropical Journal of Pharmaceutical
Research, December 2002; 1 : 115-122.
2. The International Pharmacopoeia,
World Health Organization, Geneva,
third edition, volume 5(2003) : 7-11
3. N Srujana, Pooja Balachandra, MP
Venkatesh, Balamuralidhara V and TM
Pramod Kumar: A Comparative Study of
In-Process and Finished Products
Quality Control Tests for Ophthalmic
Products in Different Pharmacopoeias
International Journal of Pharmacy
Teaching & Practices 2012; 3 : 261-265
4. Key Challenges to US Topical Ocular
Drug Development,
http://www.quintiles.com/elements/me
dia/experts/key-challenges-us-topicalocular-
drug- development.pdf.
Accessed 31 July 2012
5. Guide to Inspections of Sterile Drug
Substance Manufacturers,
http://www.fda.gov/ICECI/Inspections/I
nspectionGuides/ucm074930.html.
Accessed 31 July 2012
6. Media fill Validation-SVP,
http://www.pharmaguideline.com/2011
/04/media-fill-validation-svp.html.
Accessed 1 August 2012
7. Ophthalmic Preparations,
http://www.newdruginfo.com/pharmac
opeia/usp28/v28230/usp28nf23s0_c115
1s44.html . Accessed 2 August 2012

Thank you for copying data from http://www.arastirmax.com